Following the establishment of its predecessor, IBRD Japan, ASKLEP since 1992 has been meeting the needs of pharmaceutical manufacturers by providing contract research organization (CRO) services to the Japanese market. In addition to clinical monitoring, data management and biostatistical analysis, ASKLEP has fused information technology functions with medical marketing research cultivated within the INTAGE Group, the result of which allows us to provide real-time solutions in decision-making processes.
By incorporating in-house consulting services and global capabilities through collaborations with CROs around the world, ASKLEP proposes a CRO business model that goes beyond the conventional framework.
■ Service Line-up
● Clinical monitoring and project management
● Data management and EDC
● Biostatistical Analysis
● Medical Writing
● Registration
● Education and Training (CRA)
● Consultation (development strategy, regulatory/submissions, others)
● Site Management Organization (SMO)
